logo
logo
Sign in

Blood Testing Market, Competitive Landscape with Top Players – Novartis Diagnostics, Abbott Laboratories Inc., Baxter International | Forecast – 2023

avatar
Shubhra Ketan
Blood Testing Market, Competitive Landscape with Top Players – Novartis Diagnostics, Abbott Laboratories Inc., Baxter International | Forecast – 2023

The global blood testing market report by Market Research Future (MRFR) outlines numerous drivers, challenges, upcoming trends, and growth opportunities pertinent for users to succeed in the forecast period of 2017 to 2023.

Blood Testing Market Analysis

Blood Testing provides more of a high-level overview and in-depth details on more specific aspects of health functions alongside indicating current and potential health risks. Integration of several powerful technologies such as Artificial Intelligence (AI) has made the blood testing more effective.  An AI-powered blood test consisting of one clinical variable and six biomarkers predicted with high accuracy the presence of peripheral artery disease and the need for revascularization in patients with and without diabetes.

Recognizing the exponential growth, the market perceives currently and gauging the potential the market holds to grow in the years to come; Market Research Future (MRFR), in its recently published market forecast asserts that the global blood testing market will grow exponentially by 2023, registering approximately 5.5% during the review period (2017 – 2023).

Additional factors supporting the market growth include the ever-increasing population that is getting inclined towards the sedentary lifestyle and urbanization. Improving economic conditions are rapidly availing access to the excellent health care, increasing the healthcare expenditures and eventually the market growth.

Conversely, lack of awareness towards the availability and advantages of blood testing is obstructing the market growth.  Also, the unmet clinical needs coupled with the unavailability of external funding; especially in the developing regions are obstructing the market growth. Nevertheless, increasing demand for personal & hand-held diagnostic devices & augmenting demand for the blood testing in the diagnostics that can give fastest & accurate results is fostering the market growth. 

Get a FREE Sample with Complete TOC By Considering the COVID-19 impact on Global Market @ https://www.marketresearchfuture.com/sample_request/5797

Global Blood Testing Market – Regional Analysis

The North America market is expected to retain its dominance over the global blood testing market with the largest market share. A well-developed healthcare sector, increasing prevalence of chronic diseases such as diabetes and cancer especially in the US & Canada along with the high per capita healthcare expenditures drive the market growth in the region. This market will create a substantial revenue pocket registering a substantial CAGR throughout the forecast period (2017-2023). Furthermore, the presence of prominent market players impacts the market growth positively.

Europe & Asia Pacific region accounts for the second & third largest market respectively for the blood test.  The European blood testing market is growing due to the increasing awareness of chronic infectious diseases, the initiatives undertaken by private and public organizations, and well-spread awareness towards keeping the good health.

The Asia Pacific region is emerging as one of the promising markets for the blood testing. This attributes to the increasing healthcare expenditures and favorable government policies of developing economies like India and China.

Factors substantiating the market growth in the APAC region include the substantial funds transpired into R&D activities, huge patient population, well-developed healthcare infrastructure, and government support. Simultaneously, economies having high healthcare expenditures such as India, China, and Japan propel the market growth in the region. 

Global Blood Testing Market – Segments

The report is segmented into five dynamics:

By Test TypeDirect LDL Testing, Glucose Testing, Lipid Panel Testing, Prostate Specific Antigen (PSA) Testing, A1C Testing, Blood Urea Nitrogen (BUN) Testing, High Sensitivity C-Reactive Protein (hs-CRP) Testing, Alt Testing, Vitamin D Testing, Thyroid Stimulating Hormone Testing, Serum Nicotine/Cotinine Testing, Creatinine Testing, AST Testing, Testosterone Testing, Cortisol Testing, and others.

By DiseaseInfection, Anemia, Leukemia, Kidney Disorders, Hypokalemia, Coronary Heart Disease, Heart Attack, and other diseases.

By Method: Automated Blood Culture Testing, Manual Blood Culture Testing, and others.

By End-UserHospitals, Clinics, Diagnostic Centers, Research Labs, and others.

By Regions:  Europe, Americas, Asia Pacific, and the Rest-of-the-World (RoW). 

Global Blood Testing Market – Competitive Analysis

The market for blood testing appears fragmented and fiercely competitive due to many large and small players churning the competition in the market.  Through the strategic partnership, acquisition, expansion, product & technology launch, and collaboration, these players try to gain the competitive edge.

Blood Testing Market Major Players: 

The global blood Testing market is led by some of the fervent players including Baxter International (U.S.), Abbott Laboratories Inc. (U.S.), Gen-Probe, Inc. (U.S.), Trinity Biotech (U.S.), Siemens Healthcare (Germany), Bio-Rad Laboratories Inc. (U.S.), Grifols (Spain), bioMérieux (France), Nanosphere Inc. (U.S.), Roche Diagnostics (Switzerland), Bruker Corporation (U.S.), Becton Dickinson & Company (U.S.), Novartis Diagnostics (U.S.), Biomerica, Inc. (U.S.), Meridian Bioscience, Inc. (U.S.), Cepheid Corporation (U.S.), Alere Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.) Cardinal Health (U.S.), Beckman Coulter (U.S.), Danaher Corporation (U.S.), and Trividia Health (U.S.), among others.

July 9, 2020 ---- American company SomaLogic Inc. and Japanese electronics conglomerate NEC Corp. launched a joint venture (JV) to bring the Boulder company’s blood-testing platform to the Japanese market. The JV - FonesLife Corp. will sell the SomaSignal line of tests for broader use in Japan. The testing platform analyzes proteins in a patient’s blood that may signal current health and risk of future diseases, such as heart attacks or stroke. SomaLogic is a privately owned American protein biomarker discovery and clinical diagnostics company. NEC Corp. is a multinational information technology and electronics company.

Obtain Premium Research Report Details, Considering the impact of COVID-19 @ https://www.marketresearchfuture.com/reports/blood-testing-market-5797

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

+1 646 845 9312

Email: [email protected]

NOTE: Our team of researchers are studying Covid-19 and its impact on various industry verticals and wherever required we will be considering covid-19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

collect
0
avatar
Shubhra Ketan
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more